Clinical Trials Logo

Delirium clinical trials

View clinical trials related to Delirium.

Filter by:

NCT ID: NCT06460363 Not yet recruiting - Delirium Clinical Trials

Transcranial Alternating Current Stimulation on Patients With Delirium and Critical Illness (DeliTACS)

DeliTACS
Start date: September 1, 2024
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to learn if transcranial alternating current stimulation can shorten the duration of delirium in intensive care setting. The main question it aims to answer: - Is it possible to shorten the duration of delirium with transcranial alternating current stimulation? Researchers will compare experimental treatment to sham. Participants will receive experimental or sham treatment on maximum of two days depending on their delirium status. Duration of delirium is recorded and reported as "days alive and free of delirium".

NCT ID: NCT06445153 Recruiting - Clinical trials for Postoperative Delirium

Digitalized Clinical Decision Support for the Prevention of Postoperative Delirium (POD)

Start date: June 3, 2024
Phase: N/A
Study type: Interventional

The project aims to improve patient safety, reduce barriers to the implementation of current guideline recommendations, reduce workload in clinics, increase efficiency in work processes and close gaps in care.

NCT ID: NCT06443957 Completed - Clinical trials for Postoperative Delirium

The Preventive Effect of Different Doses of Intranasal Insulin on Postoperative Delirium

Start date: July 29, 2023
Phase: N/A
Study type: Interventional

Postoperative delirium is one of the common complications in the older aldults after surgery, which can lead to longer hospita stay,memory loss and reduced quality of life. There is currently no specific treatment. Therefore, it is important to prevent the occurrence of postoperative delirium. This study investigated the effect of intranasal insulin administration on the prevention of postoperative delirium and compared different doses of insulin to find a safe and acceptable method for preventing delirium.

NCT ID: NCT06434948 Not yet recruiting - Clinical trials for Postoperative Delirium

The Effect of Omega 3 Supplementation on Postoperative Delirium in Elderly Patients Undergoing Major Cardiac Surgery

Start date: June 2024
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine whether giving omega-3 fatty acids prior to and after cardiac bypass surgeries decreases the incidence of postoperative delirium in patients aged 65 and over.

NCT ID: NCT06423547 Not yet recruiting - Surgery Clinical Trials

Risk Warning Model of Postoperative Delirium and Long-term Cognitive Dysfunction in Elderly Patients

Start date: June 15, 2024
Phase:
Study type: Observational [Patient Registry]

The incidence of postoperative delirium in elderly patients is high, which can lead to long-term postoperative neurocognitive disorders. Its high risk factors are not yet clear. At present, there is a lack of early diagnosis and alarm technology for perioperative neurocognitive disorders, which can not achieve early intervention and effective treatment. By artificial intelligence and autonomously evolutionary neural network algorithm, relying on multi-source clinical big data, we explored the use of Bayesian network to optimize the anesthesia decision-making system in enhanced recovery after surgery, and established risk prediction model for perioperative critical events. It is expected that this method will also help to establish a risk prediction model for postoperative delirium and long-term postoperative neurocognitive disorders. This project plans to collect the perioperative sensitive parameters of anesthesia machine, multi-parameter monitor, EEG monitor,fMRI and HIS system, to explore the evolution process of data characteristics by feature fusion.We also plan to quickly screen key perioperative risk characteristics of postoperative delirium from massive clinical data through feature selection, to explore the high risk factors of long-term postoperative neurocognitive disorders developing from postoperative delirium. Finally, with multi-center intelligent analysis,the risk prediction model of postoperative delirium and long-term postoperative neurocognitive disorders will be constructed.

NCT ID: NCT06421090 Recruiting - Clinical trials for Vagus Nerve Stimulation

Transauricular Vagal Nerve Stimulation Improves Postoperative Delirium in Elderly Patients

Vnstar-IIa
Start date: May 21, 2024
Phase: N/A
Study type: Interventional

To investigate the efficacy and safety of perioperative Transauricular vagal nerve stimulation in improving Postoperative Delirium in elderly patients undergoing elective surgery Lay the groundwork for a Phase III study.

NCT ID: NCT06421077 Recruiting - Clinical trials for Vagus Nerve Stimulation

Transauricular Vagus Nerve Stimulation Improves Postoperative Delirium in Elderly Patients

Vnstar
Start date: May 21, 2024
Phase: N/A
Study type: Interventional

According to the 3D-CAM scale, evaluate the incidence of Postoperative Delirium within 5 days after surgery in elderly patients receiving Transauricular vagal nerve stimulation.The results are expected to provide evidence of the safety and efficacy of perioperative prophylactic use of taVNS in the clinical application of improving postoperative brain health in elderly patients, as well as theoretical and practical basis for subsequent studies or clinical applications.

NCT ID: NCT06411561 Not yet recruiting - Dementia Clinical Trials

A Multi-Modal Combination Intervention to Promote Cognitive Function in Older Intensive Care Unit Survivors

SLEEP-COG
Start date: July 1, 2024
Phase: N/A
Study type: Interventional

Up to 25% of intensive care unit (ICU) survivors experience cognitive impairment comparable in severity to mild Alzheimer's disease and related dementias after hospital discharge. Older ICU survivors (ages 60 and older) are at highest risk for delirium and subsequent cognitive impairment, which contribute to higher risk for cognitive decline related to Alzheimer's disease and related dementias. Sleep and activity are essential for recovery from critical illness, yet ICU survivors experience both sleep deficiency and profound inactivity. About 75-80% of ICU patients experience circadian dysrhythmia, which contributes to cognitive decline and increases likelihood of developing Alzheimer's disease and related dementias. The scientific premises of the proposed study are: 1) a combined sleep promotion and cognitive training intervention will have synergistic effects to mitigate the risk of cognitive impairment and development of Alzheimer's disease and related dementias in older ICU survivors; and 2) chronotherapeutic timing of interventions (i.e., adjusting timing of interventions according to circadian rhythm) may improve intervention efficacy.

NCT ID: NCT06406257 Not yet recruiting - Emergence Delirium Clinical Trials

Temperature Management on Postoperative Delirium

POD
Start date: May 20, 2024
Phase: N/A
Study type: Interventional

Presently, the effects of perioperative temperature management on postoperative delirium remain ambiguous. This study endeavors to explore the influence of intraoperative temperature variations in elderly hip fracture patients on postoperative delirium.

NCT ID: NCT06403410 Not yet recruiting - Delirium Clinical Trials

Delirium Prevention Guideline for Intensive Care Patients

Start date: June 15, 2024
Phase: N/A
Study type: Interventional

Delirium is a complication characterized by fluctuations in orientation, memory, thinking, or behavior, with sudden onset of these changes. Studies have shown that pharmacological agents are the most significant risk factors for delirium in intensive care units. In recent years, the impact of non-pharmacological interventions in preventing delirium development has started to be discussed.